Document ID: chunk:federal_register_of_legislation:F2025C00211:reg:5:p7
Version: federal_register_of_legislation:F2025C00211
Segment Type: reg
Provision Reference: reg 5 (pt 7/9)
Character Range: 106259–108878

Secretary for a variation of the period during which the importation of the drug may be effected;
the Secretary or an authorised person may, by writing endorsed on, or attached to, the permission, specify a period other than the period specified in the permission as the period during which the importation of the drug may be effected.
 (16) Where the Secretary or an authorised person has specified a period under subregulation (15) in relation to the importation of a drug, that period shall, for the purposes of paragraph (1)(c), be deemed to be the period specified in the permission.
 (17) Where the holder of a licence to import drugs fails to comply with a condition or requirement set out in subregulation (9), the Secretary or an authorised person may revoke the licence, whether or not the holder of the licence is charged with an offence against subsection 50(4) of the Act in respect of the failure to comply with the condition or requirements.
 (18) Where:
 (a) a permission to import a drug specifies a condition or requirement to be complied with by the holder of the permission; and
 (b) the holder of the permission fails to comply with the condition or requirement;
the Secretary or an authorised person may revoke the permission, whether or not the holder of the permission is charged with an offence against subsection 50(4) of the Act in respect of the failure to comply with the condition or requirement.
 (18A) Where the Secretary or an authorised person makes a decision:
 (a) not to grant under subregulation (5) a licence to import drugs, or a permission to import a drug; or
 (b) to grant under subregulation (13) a permission, to import a drug, that specifies:
 (i) a condition or requirement to be complied with; or
 (ii) a time at which a condition or requirement specified in the permission is to be complied with; or
 (c) not to specify under subregulation (15) a period, other than the period specified in a permission, as the period during which the importation of a drug may be effected; or
 (d) to revoke under subregulation (17) a licence to import drugs; or
 (e) to revoke under subregulation (18) a permission to import a drug;
the Secretary or the authorised person, as the case requires, must give to the applicant or the holder of the licence or the holder of the permission, as the case requires, notice in writing setting out the decision as soon as practicable after the making of the decision.
 (19) The Secretary shall, before the commencement of each year, cause to be published in the Gazette in relation to that year, a notice entitled 'Movements of Drugs of Dependence